CAACB Team

James Leung, PhD
Project Lead, CAACB
Visiting Scientist, MIT
leungjc@mit.edu

Stacy Springs, PhD
Executive Director, CAACB
Director BioMAN Research Program, MIT CBI
ssprings@mit.edu

Michael E. Wiebe, PhD
Project Lead, CAACB
President and Founder, Quantum Consulting
quantumco@comcast.net

Anthony Sinskey, ScD
Faculty Director, CBI
Professor of Biology and Health Sciences and Technology, MIT

Alnylam Pharmaceuticals (www.alnylam.com)

Amgen (www.amgen.com)

Baxter (www.baxter.com)

Biogen Idec (www.biogenidec.com)

BioMarin (www.bmrn.com)

Genentech (www.gene.com)

Genzyme (www.genzyme.com)

Merrimack Pharmaceuticals (www.merrimackpharma.com)

Sanofi (www.sanofi.com)

sanofi pasteur (www.sanofipasteur.com)

Dr. Kurt Brorson
Staff Scientist, Division of Monoclonal Antibodies, CDER/FDA

Dr. Marshall Dinowitz
Partner and Sr. Consultant, Pacific BioDevelopment LLC

Dr. Jim Gombold
Director, Testing Services, Charles River Laboratories

Dr. Bill Lucas
Director of Assay Development, WuXi AppTec Inc.

Dr. Carol Marcus-Sekura
Executive Vice President, BASI

Dr. Raymond Nims
Sr. Consultant, RMC Pharma

Dr. Anton Steuer
Principal Scientist, Program Management and Development, BioReliance

Dr. Hannelore Willkommen
Directorate, RBS Consulting

Dr. Ruth Wolff
Director of Therapeutics, Biologics Consulting Group